Adam F. Cohen

Aix-Marseille Université — France

Medicine · Health Sciences

54h-index11.0kcitations437works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmaceutical studies and practices(21), Health Systems, Economic Evaluations, Quality of Life(20), Asthma and respiratory diseases(18), Neuroscience and Neuropharmacology Research(18), Statistical Methods in Clinical Trials(16)

Publications435 total

Clonazepam repurposing in <i>ARID1B</i> patients through conventional RCT and N-of-1 trials: an experimental strategy for orphan disease development
Journal of Medical Genetics·2024· 1 citedOpen Access
An Assessment of the Viva CalleSJ Event in San Jose
2024
LBA8 Precision immuno-oncology for advanced non-small cell lung cancer (NSCLC) patients with PD-(L)1 inhibitors resistance (PIONeeR): A phase Ib/IIa clinical trial targeting identified resistance pathways
Annals of Oncology·2024· 5 cited
P-008 A Rare and Unexplored Entity of Colitis Post-BCMA Directed CAR T-Cell Therapy; Insights From a Multicenter Case Series
Clinical Lymphoma Myeloma & Leukemia·2024· 3 cited
On the use of open‐label studies for the evaluation of cannabis‐based products for the treatment of long COVID
British Journal of Clinical Pharmacology·2024Open Access
On-Demand Services for Mobility, Logistics, Emergency Response, and Humanitarian Use Cases
Transportation Research Board eBooks·2024
The Effect of Social Demographics on Optune Usage Amongst Patients with Glioblastoma (P6-5.020)
Neurology·2024
Human hypoxia models in aerospace medicine: Potential applications for human pharmacological research
British Journal of Clinical Pharmacology·2024· 4 citedOpen Access
Clonazepam repurposing in ARID1B patients through conventional RCT and N-of-1 Trials - An experimental strategy for orphan disease development
Research Square (Research Square)·2024Open Access
Cardiac age detected by machine learning applied to the surface ECG of healthy subjects: Creation of a benchmark
2024
Preparation for the next pandemic-a plea for a nationalized approach
2024Open Access
Disproportional inflation of clinical trial costs: why we should care, and what we should do about it
Nature Reviews Drug Discovery·2024· 3 cited
The <i>British Journal of Clinical Pharmacology</i>: The first 50 years
British Journal of Clinical Pharmacology·2023· 1 citedOpen Access
A smartphone- and wearable-based biomarker for the estimation of unipolar depression severity
Scientific Reports·2023· 7 citedOpen Access
[Clinical research: who owns the data?]
PubMed·2023
P-240 Efficacy and safety of ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma and prior noncellular anti-BCMA therapy: CARTITUDE-2 cohort C
Clinical Lymphoma Myeloma & Leukemia·2023
Human Hypoxia Models: From Space Medicine to Human Pharmacological Studies
2023Open Access
Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke
JAMA Neurology·2023· 17 citedOpen Access
A Telemedicine Platform to Increase Access to Migraine Care in Men (P8-12.009)
Neurology·2023
Supplementary Figure Legend from GITR Pathway Activation Abrogates Tumor Immune Suppression through Loss of Regulatory T-cell Lineage Stability
2023Open Access
page 1 of 22Next →

Frequent Co-authors

Rik C. Schoemaker(23), Jacobus Burggraaf(17), Joop van Gerven(11), D. D. Breimer(7), Eef G.W.M. Lentjes(6), Saco J. de Visser(5), Olga Weijtens(5), Fred P.H.T.M. Romijn(5), Monique S. M. Pieters(4), Alfred L van Steveninck(4), Marieke L. de Kam(4), Jan C. van Meurs(4), Jules A. A. C. Heuberger(4), Sanne de Haas(3), Hanno Pijl(3), Martijn B. A. van Doorn(3), J. P. Van Der Post(3), M. S. M. Pieters(3), Al de Weerd(2), Andreas Otte(2)